argenx
argenx is seeking a senior statistical leader to advance biomarker analytics and translational data science across autoimmune clinical programs. The role supports development of differentiated medicines by shaping biomarker-driven study design, reproducible analysis practices, and data products to inform decision making across the organization.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2008
Reaching Patients Through Immunology Innovation
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for argenx.
argenx didn’t post a salary, so this is our estimate from similar listings.
OMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Principal Biostatistician (Biomarker Biostatistics Lead)
ICON plc
Principal Biomarker Biostatistician
Sanofi
Biomarker Analysis Scientist
Amgen
Head of Quantitative Biomarker Sciences (all genders)
Evotec
Associate Director, Global Biomarker Lead, Inflammation, GI2 TAU
BioLife Plasma Services
Associate Director, Data Science, Neuroscience Biomarker Discovery
MSD